While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance ...

The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a ...

Pinnacle Medicines ("Pinnacle" or "the Company"), a biotechnology company pioneering the development of oral peptide therapeutics using proprietary AI and physics-based platforms, today announced the ...

Leading Healthcare-Focused Investor Expands Capabilities to Provide Comprehensive Suite of Equity, Debt, Royalty, and Hybrid Financing Solutions for Commercial Stage Companies Industry Veterans Jeremy ...

LA JOLLA, Calif., March 13, 2026 (GLOBE NEWSWIRE)-- Equillium, Inc. (“Equillium” or the “Company”) (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...

RA Capital released its latest quarterly 13F fund update with the SEC last week, showcasing new positions in the multi-stage healthcare and life science-focused fund. The Boston-based fund has emerged ...

Launching a new product is challenging, but doing it in a space dominated by tech giants requires bold innovation, sharp strategy, and the ability to scale quickly. TechCrunch Disrupt 2024 — taking ...

Biopharma hedge funds have been on a buying spree the past several weeks. Many of them reported in regulatory filings that they have initiated positions of at least 5 percent in individual stocks or ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. RA Capital released its latest quarterly 13F fund update ...